Загрузка...

Both Fidaxomicin and Vancomycin Inhibit Outgrowth of Clostridium difficile Spores

Fidaxomicin (FDX) is approved to treat Clostridium difficile-associated diarrhea and is superior to vancomycin in providing a sustained clinical response (cure without recurrence in the subsequent 25 days). The mechanism(s) behind the low recurrence rate of FDX-treated patients could be multifactori...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Allen, Charlotte A., Babakhani, Farah, Sears, Pam, Nguyen, Ly, Sorg, Joseph A.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2013
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535933/
https://ncbi.nlm.nih.gov/pubmed/23147724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01611-12
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!